Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Egetis Therapeutics

5.37 SEK

+0.19 %

Less than 1K followers

EGTX

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Egetis Therapeutics

2019202020212022202320242025
Revenue82.640.722.622.657.646.162.4
growth-%-50.7 %-44.4 %0.0 %154.9 %-20.0 %35.4 %
EBITDA-66.5-178.0-58.8-195.4-321.2-302.4-
EBIT-66.7-178.4-61.3-198.1-324.8-329.4-339.9
Profit before taxes-61.4-179.1-60.0-193.8-326.8-343.2-342.1
Net income-61.4-179.1-128.0-193.8-326.9-343.6-342.5
EPS-1.08-2.44-0.71-1.00-1.30-1.10-0.90
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-80.5 %-437.8 %-260.3 %-864.6 %-557.6 %-656.0 %
EBIT-%-80.8 %-438.7 %-271.1 %-876.5 %-563.9 %-714.5 %-544.7 %
ROE-25.1 %-28.4 %-24.3 %-38.3 %-59.9 %-69.7 %-101.1 %
ROI-22.7 %-20.0 %-22.5 %-34.5 %-43.0 %-43.4 %-53.6 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.